Dr Reddy's Laboratories Ltd (NYSE:RDY)
| 70.91 Delayed Data As of 4:00pm ET |  -0.49 / -0.69%Today’s Change | 51.12 Today|||52-Week Range 74.42 | -0.53% Year-to-Date |
Latest RDY News | Press Releases
| Why Amarin Fell Again Today Jun 22 / MotleyFool.com - Paid Partner Content | Why Amarin Stock Is Sinking Today Jun 21 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 71.40 |
| Today’s open | 71.05 |
| Day’s range | 70.64 - 71.34 |
| Volume | 94,809 |
| Average volume (3 months) | 163,576 |
| Market cap | $11.9B |
Data as of 4:00pm ET, 06/24/2021
Growth & Valuation
| Earnings growth (last year) | -6.23% |
| Earnings growth (this year) | +71.15% |
| Earnings growth (next 5 years) | +19.00% |
| Revenue growth (last year) | +3.79% |
| P/E ratio | 41.2 |
| Price/Sales | -- |
| Price/Book | -- |
Competitors
| ---- | ||
| JAZZJazz Pharmaceuticals... | +1.78 | +1.01% |
| BHCValeant Pharmaceutic... | +0.64 | +2.20% |
| RGENRepligen Corp | +0.08 | +0.04% |
Data as of 4:00pm ET, 06/24/2021
Financials
| Next reporting date | August 4, 2021 |
| EPS forecast (this quarter) | $0.57 |
| Annual revenue (last year) | $2.6B |
| Annual profit (last year) | $258.0M |
| Net profit margin | 10.09% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Generic |
No executives to display |
Corporate headquarters Hyderabad, Telangana |
Forecasts
